FEN1 and breast carcinoma: Our previous study demonstrated that overexpression of microRNA-140 (miR-140) could enhance the drug sensitivity of breast cancer cells and reduce the drug resistance of adriamycin-resistant breast cancer cells by targeting FEN1 [17].